PROCEPT BioRobotics (PRCT) Current Assets (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Current Assets for 7 consecutive years, with $420.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets fell 8.25% year-over-year to $420.3 million in Q2 2026; TTM through Jun 2026 was $420.3 million, a 8.25% decrease from a year earlier, with the FY2025 full-year figure at $450.4 million, down 6.53% from the prior year.
• Current Assets was $420.3 million for Q2 2026 at PROCEPT BioRobotics, down from $428.0 million in the prior quarter.
• Over five years, Current Assets peaked at $481.8 million in Q4 2024 and troughed at $230.0 million in Q2 2023.
• A 5-year average of $360.9 million and a median of $339.9 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets decreased 22.9% in 2023 and surged 42.3% in 2025, its largest moves.
• Over 5 years, Current Assets stood at $272.6 million in 2022, then rose by 28.59% to $350.6 million in 2023, then jumped by 37.45% to $481.8 million in 2024, then declined by 6.53% to $450.4 million in 2025, then slipped by 6.68% to $420.3 million in 2026.
• The last three Current Assets figures came in at $420.3 million (Q2 2026), $428.0 million (Q1 2026), and $450.4 million (Q4 2025), per Business Quant data.